| 项目编号 |
PRJCA040153 |
| 项目标题 |
Targeting sialylation enhances the therapeutic efficacy of Enfortumab Vedotin in bladder cancer |
| 涉及领域 |
Medical |
| 数据类型 |
Transcriptome or Gene expression
|
| 物种名称 |
Homo sapiens
|
| 描述信息 |
Transcriptome sequencing was performed on the RT-112 and KU-19-19 cell lines to explore the potential mechanisms influencing the antitumor effect of enfortumab vedotin. |
| 样品范围 |
Multiisolate |
| 发布日期 |
2025-09-03 |
| 出版信息 |
| PubMed ID |
文章标题 |
杂志名称 |
Doi |
发表年份 |
| 41066596
|
Targeting Sialylation Enhances the Therapeutic Efficacy of the Nectin-4-Targeted Antibody-Drug Conjugate Enfortumab Vedotin in Bladder Cancer
|
Cancer Research
|
10.1158/0008-5472.CAN-25-0024
|
2025
|
|
|
| 项目资金来源 |
| 机构 |
项目类型 |
授权项目ID |
授权项目名称 |
| Noncommunicable Chronic Diseases-National Science and Technology Major Project
|
|
2024ZD0525700
|
|
|
|
| 提交者 |
Tao
Xu (xutao@pkuph.edu.cn)
|
| 提交单位 |
Peking University People's Hospital |
| 提交日期 |
2025-05-14 |
